Clinical trial
Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of…
NCT00101452 · Maurizio Fava, MD, Other · Completed
Key facts
| NCT number | NCT00101452 |
|---|---|
| Title | Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression |
| Official title | A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-Adenosyl-L-Methionine (SAMe) vs Escitalopram in Major Depressive Disorder (MDD) |
| Lead sponsor | Maurizio Fava, MD, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | S-adenosyl-l-methionine, Escitalopram, Placebo |
| Enrollment | 199 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jan 11, 2005 |
| Last update posted | Apr 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: